– USA, TN – Healthcare Realty Trust Incorporated (NYSE: HR) today announced that David Emery, Executive Chairman, has taken medical leave.
On September 10, 2019, the Company’s board of directors elected its lead independent director, J. Knox Singleton, to serve as independent Chairman. Mr. Singleton retired in 2018 as CEO of Inova Health System and has been a long-standing board member of Healthcare Realty, serving most recently as chair of the compensation committee.
Mr. Singleton said, “David built a phenomenal company, and over the last few years, he led a thoughtful management transition and refresh of our board. We are well prepared to continue the strategy and extend the success that David started.”
Mr. Emery will remain a board member while on medical leave. In recognition of his founding of Healthcare Realty and meritorious leadership since its inception, the board of directors has bestowed on Mr. Emery the title of Chairman Emeritus.
Mr. Emery led the team that founded Healthcare Realty in 1992 and oversaw its initial public offering on the New York Stock Exchange in 1993, raising $117 million to fund an initial portfolio of 21 properties. As Chairman and CEO, Mr. Emery guided the Company’s steady growth from a net leased portfolio to a well-differentiated, fully-integrated operating company with 282 employees that acquires, develops, owns and operates premium medical office buildings. The Company now owns 200 properties valued at over $5.7 billion.
Todd Meredith, President and CEO, expressed, “On behalf of my colleagues at Healthcare Realty, we are grateful for David’s vision and leadership. We are fortunate to know David as a great friend and mentor. He is an inspiration to us all. We wish David and his family the best during this difficult time.”
For more information: https://www.healthcarerealty.com
- Disclaimer - News, data and statement included in this release are intended exclusively for general information purposes. Talent4Boards accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the adequacy or accuracy of the information. No data or statement in this release should be considered for decisions about securities referred. Product and brand names used in this release maybe trademarks or registered trademarks of their respective owners.
Comments are closed.